Back to Search Start Over

Clinical significance of the ratio of acceleration time to ejection time in severe aortic stenosis

Authors :
A. Altes
Franck Levy
A. Mailliet
Anne Ringle
Sylvestre Maréchaux
Anne-Laure Castel
François Delelis
Y. Bohbot
N. Thellier
Christophe Tribouilloy
Source :
Archives of Cardiovascular Diseases Supplements. 13:248-249
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Introduction The ratio of acceleration time to ejection time (AT/ET) is a simple and reproducible echocardiographic parameter that integrates AS severity and its consequences on the LV. The prognostic impact of AT/ET on outcome in patients with SAS and no or mild symptoms has not been investigated. This study sought to determine the prognostic impact of AT/ET on mortality in patients with severe aortic stenosis (SAS), preserved left ventricular ejection fraction (LVEF) and no or only mild symptoms. Method Three hundred and fifty-three patients [median age 79 (71–85), 46% women] with high gradient [mean pressure gradient ≥ 40 mmHg and/or aortic peak jet velocity (Vmax)≥4 m/s] SAS, LVEF ≥ 50% and no or only mild AS symptoms were studied. Patients were retrospectively stratified by AT/ET ≤ or > 0.35. Survival analyses were carried out to study the impact of AT/ET on all-cause mortality. Results During a median follow-up of 39 (23–62) months, 70 patients died. AT/ET > 0.35 was associated with a considerable increased mortality risk after adjustment for established prognostic factors in SAS when the entire follow up (medical and/or surgical management) was considered [adjusted HR 2.54 (95%CI,1 .47–4.37); P 0.35 improved the predictive performance of multivariable models including established risk factors in SAS as indicated by better global model fit, reclassification, and discrimination. After propensity score matching (n = 236), increased risk of mortality persisted for patients with AT/ET > 0.35 compared with those with AT/ET ≤ 0.35 [adjusted HR 2.67 (95% CI, 1.45–4.92); P = 0.002] ( Fig. 1 ). Conclusion AT/ET > 0.35 is a strong predictor of outcome in patients with SAS and no or only mild symptoms and identifies a subgroup of patients at higher risk of death who may derive benefit from earlier aortic valve replacement.

Details

ISSN :
18786480
Volume :
13
Database :
OpenAIRE
Journal :
Archives of Cardiovascular Diseases Supplements
Accession number :
edsair.doi...........3012c4a728fc06910c93ac9588cda0ea